Finnish Biobanks – FINBB
What is FINBB?
Building the world's best biobank network
The mission of Finnish Biobank Cooperative –FINBB is to enhance the competitiveness of Finnish health and biomedical research by providing researchers a centralized access to collections and services of the Finnish biobanks and their background organizations. FINBB's activities create value for its members and owners by providing services at the national level.
FINBB is a cooperative owned by six largest hospital districts and universities in Finland, and the Finnish Institute for Health and Welfare (THL). FINBB has eight member biobanks.
Since January 2020, FINBB has been the national coordinator of the European biobanking network BBMRI-ERIC. All eleven Finnish biobanks are involved in the network activities.
FINBB's Network
Member Biobanks
FINBB has eight member biobanks: six regional hospital biobanks, Arctic Biobank and THL Biobank.
Founding Partners
FINBB was founded and is owned by six largest hospital districts and universities, and the Finnish Institute for Health and Welfare (THL).
Biobank Network
In addition to the FINBB member biobanks, Blood Service Biobank and FHRB Biobank belong the Finnish biobank network. Terveystalo Biobank is a collaborator.
FinnGen
FINBB is an official partner of FinnGen biobank project. FINBB's main task is the coordination of a larger ecosystem evolving around study.
Fingenious Digital Service for Researchers
FINBB connects researchers to Finnish biomedical research via Fingenious® services, available via a digital service built to serve academic and industry researchers globally. Via Fingenious®the researcher can connect to all Finnish public biobanks with a single click including six regional hospital biobanks and the national THL Biobank.
What is a biobank?
Biobank is a collection of biological samples and associated health data. Biobanks grant access to samples and the associated data for high-quality scientific research projects and product development aiming at understanding disease mechanisms and disease prevention and developing new diagnostics and treatments.
The Biobank Act protects the rights of the donor and allows with the consent of the donor the collection and storage of samples and data in biobanks for use in various future research projects, not just ones with a predefined purpose. Finnish Medicines Agency Fimea directs and supervises the biobank activity in Finland and maintains a national biobank register. Only a registered biobank may engage in biobanking activities regulated by the Biobank Act.
News
FINBB and Finnish Biobanks Announce a Collaboration with Bayer on the Use of Finnish Biobank Samples, Biodata and Services
Finnish biobanks and Finnish Biobank Cooperative - FINBB have initiated a collaboration with Bayer AG enabling the global use of biobank samples in Bayer’s medical research. The aim of the collaboration is the mutual interest to enhance medical research and product development.
Statement: Biobank Act
STATEMENT OF THE FINNISH BIOBANKS AND FINBB on the draft for Government's proposal to Parliament for a new biobank act and certain related laws
FinnGen Will Invite 6000 Sample Donors for New Surveys by Using the New MyBiobank Portal
Six thousand biobank sample donors who are part of the FinnGen study will get an invitation to participate in new questionnaire surveys in the near future. This is the first additional study of FinnGen in which the participants are contacted directly through the biobanks. The study utilizes the new MyBiobank digital service.
